EW - Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.01 revenue of $1.53B beats by $20M
2023-07-26 16:17:15 ET
- Edwards Lifesciences press release ( NYSE: EW ): Q2 Non-GAAP EPS of $0.66 beats by $0.01 .
- Revenue of $1.53B (+11.7% Y/Y) beats by $20M .
- All product groups achieved double digit constant currency sales growth in Q2
- Q2 TAVR sales grew 9 percent; constant currency sales grew 10 percent
- Encouraging data from Edwards' Benchmark Registry at the EuroPCR medical congress
- New 2023 constant currency sales growth guidance of 10 to 13 percent.
For further details see:
Edwards Lifesciences Non-GAAP EPS of $0.66 beats by $0.01, revenue of $1.53B beats by $20M